Ab-IPL-IL-17 and the reference function blocking anti-IL-17 antibody (MAB317) were able to reverse this effect in inflamed RA fibroblasts to a similar degree, such that significantly lower concentrations of IL-6 and IL-8 were released (figure 5E,F). Here, IL6 is linked to rheumatoid arthritis.